Metabolic Health Expert Slams 60 Minutes Segment on Obesity Drug Semaglutide - aka Wegovy / Ozempic

3 Jan 2023 · 22 min
22:08

Dr. Tom Refai (Dr. Five) critiques a Jan 1 60 Minutes segment on obesity drugs, arguing the show favored Novo Nordisk's semaglutide products (Ozempic/Wegovy) and under-emphasized conflicts of interest and alternative drugs (tirzepatide/Mounjaro). He explains GLP-1 drug mechanisms, endorses their therapeutic role but stresses they are adjuncts to — not replacements for — lifestyle change. He strongly attributes the rise in obesity to the calorie-rich, refined, highly processed food environment and criticizes messaging that frames obesity as primarily genetic or blameworthy. He promotes a Flex 5 lifestyle approach (psychology, nutrition, physical activity environments, accountability) and condemns fat-shaming.

Chapters

More from Dr.

youtube.com

100M prediabetics in US. Most clueless. Don't die from ignorance. This video could save your life!

2y ago
youtube.com

Truth about antioxidants & Flexio training focus on flexibility, a personal story

3y ago
youtube.com

Is BMI racist? An expert Metabolic Health MD physician 's perspective

3y ago
youtube.com

Dr. Tom's Keynote on Inflammation & Cardiovascular Disease for the 2023 A4M Spring Congress.

3y ago
youtube.com

Vitamin D update - A Physician Nutrition Specialist's Take

4y ago
youtube.com

How NOT to DIE with HIGH BLOOD PRESSURE: Lifestyle vs Meds-which wins? 11 min might save your life!

4y ago
youtube.com

Critical lifestyle tips for controlling blood pressure | Silent killer high blood pressure | Heart

5y ago
youtube.com

Can we always be mindful? | Walk N Talk with Dr. Tom Rifai

5y ago
youtube.com

Making the most of movement – beyond exercise! | Walk n talk with Dr. Tom Rifai

5y ago
youtube.com

Intermittent vs Flexible Fasting™

6y ago
See all content